Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ABSI

Absci Corp

9.28

Aug 20 • 3:59 PM ET -0.71 (-7.11%)

9.65

Aftermarket • 5:03 PM ET +0.37 (3.99%)

Healthcare Biotechnology USA Small NASD

Peers: RXRX SDGR CERT KYMR BMRN CRNX RYTM INCY KRYS AXSM

| Held by: ARKG XBI IWM VTI VXF IWO IBB SCHA VTWO IWC

Scroll to Statements

Index	RUT
Market Cap	1.59B
Enterprise Value	1.40B
Income	-121.08M
Sales	1.56M
Book/sh	1.43
Cash/sh	1.17
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	140
IPO	Jul 22, 2021

P/E	-
Forward P/E	-
PEG	-
P/S	1020.88
P/B	6.47
P/C	7.92
P/FCF	-
EV/EBITDA	-
EV/Sales	894.40
Quick Ratio	10.63
Current Ratio	10.63
Debt/Eq	0.02
LT Debt/Eq	0.01
Option/Short	Yes / Yes

EPS (ttm)	-0.80
EPS next Y	-0.71
EPS next Q	-0.19
EPS this Y	5.21%
EPS next Y	10.73%
EPS next 5Y	15.88%
EPS past 3/5Y	9.99% -9.45%
Sales past 3/5Y	-21.31% -10.14%
EPS Y/Y TTM	15.36%
Sales Y/Y TTM	-62.28%
EPS Q/Q	11.98%
Sales Q/Q	-46.37%
Earnings	Aug 11 AMC
EPS/Sales Surpr.	-9.95% -67.38%

Insider Own	13.88%
Insider Trans	0.96%
Inst Own	83.52%
Inst Trans	2.51%
ROA	-50.57%
ROE	-57.72%
ROIC	-48.87%
Gross Margin	-610.70%
Oper. Margin	-8411.27%
Profit Margin	-7756.37%
SMA20	8.84%
SMA50	3.74%
SMA200	86.99%
Trades

Shs Outstand	171.56M
Shs Float	147.79M
Short Float	25.24%
Short Ratio	7.40
Short Interest	37.31M
52W High	12.06 -23.02%
52W Low	2.24 314.29%
Volatility	6.30% 7.06%
ATR (14)	0.71
RSI (14)	54.23
Beta	2.46
Rel Volume	0.57
Avg Volume	5.04M
Volume	2,895,411

Perf Week	-1.90%
Perf Month	12.62%
Perf Quarter	87.47%
Perf Half Y	233.81%
Perf YTD	165.90%
Perf Year	261.09%
Perf 3Y	452.38%
Perf 5Y	-58.79%
Perf 10Y	-
Recom	1.20
Target Price	13.89
Prev Close	9.99
Price	9.28
Change %	-7.11%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-04-26	Initiated	Leerink Partners	Outperform	$12
May-28-26	Initiated	BTIG Research	Buy	$9
Jan-08-26	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$4.32
Oct-02-25	Initiated	JP Morgan	Overweight
Jul-03-25	Resumed	Morgan Stanley	Overweight	$7
Jan-22-25	Initiated	Needham	Buy	$9
Oct-02-24	Initiated	Guggenheim	Buy	$10
Jul-03-24	Initiated	Morgan Stanley	Overweight	$7
Mar-14-24	Initiated	Scotiabank	Sector Outperform	$13
Dec-05-23	Initiated	KeyBanc Capital Markets	Overweight	$3
May-04-23	Initiated	H.C. Wainwright	Buy	$4
Aug-12-22	Downgrade	JP Morgan	Overweight → Underweight
Jul-18-22	Initiated	Truist	Buy	$8
Mar-02-22	Resumed	Cowen	Market Perform
Feb-01-22	Initiated	Berenberg	Buy	$28
Nov-10-21	Downgrade	BofA Securities	Neutral → Underperform	$10
Oct-15-21	Resumed	Cowen	Market Perform
Aug-16-21	Initiated	Stifel	Hold	$28
Aug-16-21	Initiated	Credit Suisse	Outperform	$40
Aug-16-21	Initiated	Cowen	Market Perform

Show Previous Ratings

Aug-11-26 08:22PM	Absci Corporation Q2 2026 Earnings Call Summary (Moby)
04:05PM	Absci Reports Business Updates and Second Quarter 2026 Financial and Operating Results (GlobeNewswire)
Aug-10-26 09:17AM	Earnings To Watch: Absci Corp (ABSI) Q2 2026 -- GF Value Sees 92% Downside (GuruFocus.com)
Jul-24-26 09:10AM	A Small AI Company Just Took the Stage at One of the Biggest Events in Computing, and It Points to Where Drug Discovery Is Headed (PR Newswire) -6.32%
Jul-15-26 08:45AM	As AI Rewrites Drug Discovery, This Bio-Native AI Company Just Joined the Russell 3000E, and Reports Earnings July 22 (PR Newswire)
04:05PM	Loading…
Jul-14-26 04:05PM	Absci to Report Business Updates and Second Quarter 2026 Financial and Operating Results on August 11, 2026 (GlobeNewswire)
Jul-06-26 08:55AM	As AI Models Become Commodities, a Bio-Native AI Company Just Moved to Patent the Data Layer Beneath the Models (PR Newswire)
08:45AM	The Quantum Sector Hits an Inflection Point: Federal Money, Real Milestones, and a Security Race Running in Parallel (PR Newswire)
Jun-26-26 02:39PM	Healthcare stocks have become a haven for investors ditching tech (MarketWatch) +6.66%
06:27AM	Lilly-backed Absci banks $100m to progress endometriosis, hair loss therapy (Pharmaceutical Technology)
Jun-24-26 11:24PM	Why Did UAL, GLW, ABSI Stocks Surge To 52-Week Highs Today? (Stocktwits) +35.96%
03:55PM	ABSI Stock Eyes Best Day Ever After Positive Hair Loss Drug Data, $100M Lilly-Backed Raise (Stocktwits)
08:59AM	Absci Shares Soar After Positive Early Clinical Results for Hair Loss Therapy (ABSI) (InvestorsHub)
08:07AM	Absci, FuelCell Energy surge premarket; Cerebras, FedEx tumble (Investing.com)
06:35AM	Absci Announces Pricing of $100 Million Underwritten Offering with Leading Strategic and Financial Investors (GlobeNewswire)
06:30AM	Loading…
06:30AM	Absci Announces Positive Interim Phase 1 Data from the HEADLINE Trial of ABS-201, a Novel Antibody Targeting the Prolactin Receptor (PRLR) (GlobeNewswire)
Jun-16-26 08:45AM	The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It (PR Newswire)
Jun-12-26 09:00AM	MindWalk (NASDAQ: HYFT) CEO Dr. Jennifer Bath to Join Absci (NASDAQ: ABSI) and a Leading AI Compute Provider on Jones AI Day Panel on the Future of AI Drug Discovery (Business Wire)
May-20-26 08:00AM	Absci to Participate in Upcoming Investor Conferences (GlobeNewswire) +6.91%
May-13-26 11:11AM	Marvell Stock Climbs After AMD Reveals Surprise Stake (GuruFocus.com)
May-07-26 04:05PM	Absci Reports Business Updates and First Quarter 2026 Financial and Operating Results (GlobeNewswire)
May-06-26 09:28AM	Absci Corp (ABSI) Q1 2026 Earnings Report Preview: What To Look For (GuruFocus.com) +6.06%
May-04-26 08:11PM	Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +14.23%
Apr-23-26 04:05PM	Absci to Report Business Updates and First Quarter 2026 Financial and Operating Results on May 7, 2026 (GlobeNewswire) +7.88%
Apr-08-26 08:00AM	Absci to Participate in the 25th Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-25-26 08:30AM	Absci Corporation Q4 2025 Earnings Call Summary (Moby)
Mar-24-26 11:01PM	Absci Corp (ABSI) Q4 2025 Earnings Call Highlights: Strategic Advances and Financial Resilience (GuruFocus.com)
04:05PM	Absci Reports Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results (GlobeNewswire)
08:00AM	Absci Launches ABS-201 Endometriosis Advisory Board with Leading Experts from Yale, UCSF, Duke, and the Mayo Clinic (GlobeNewswire)
Mar-23-26 09:17AM	Earnings To Watch: Absci Corp (ABSI) Reports Q4 2025 Result (GuruFocus.com)
04:05PM	Loading…
Mar-06-26 04:05PM	Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -8.11% +5.46%
Mar-03-26 08:00AM	Absci Strengthens Clinical Leadership with Appointment of Ransi Somaratne, M.D., FACC, MBA as Chief Medical Officer (GlobeNewswire) -8.21%
Mar-02-26 12:15PM	Absci Conference: Agentic AI Push and ABS-201 Hair-Loss Program Take Center Stage (MarketBeat)
Feb-24-26 08:00AM	Absci to Report Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results on March 24, 2026 (GlobeNewswire)
Feb-17-26 08:00AM	Absci to Participate in Upcoming Investor Conferences (GlobeNewswire)
Jan-14-26 09:07PM	Absci Unveils Origin-1 AI Model, Teases 2025 Hair-Loss Data and Q4 Endometriosis Trial Launch (MarketBeat) -8.96%
02:13PM	Analysts Cut Absci (ABSI) Target, Spotlight New Alopecia Therapy in Early Trials (Insider Monkey)
Dec-31-25 11:13AM	Absci Unveils Preclinical Data for AI-Designed ABS-201, Targeting a Novel Hormonal Pathway for Hair Loss Treatment (Insider Monkey)
Dec-30-25 12:18PM	Absci Corporation (ABSI) Announces First Participants Dosed In Phase 1/2a HEADLINE Trial (Insider Monkey)
Dec-27-25 07:43AM	Absci Corporation (ABSI) Draws Full Buy Consensus With 150% Upside Potential (Insider Monkey)
Dec-18-25 01:14AM	Absci Corporation (NASDAQ:ABSI)'s ABS-201 Shows Promise in Hair Loss Treatment, Analysts See Upside (Insider Monkey)
Dec-16-25 08:00AM	Absci to Participate in the 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-12-25 10:15AM	AI Creation Engines Transform Biotech as Wellness Tech Captures Growth Wave (PR Newswire) -5.21%
Dec-11-25 08:00AM	Absci Reports New Human Ex Vivo Data Demonstrating That ABS-201 Stimulates Hair Growth and Regenerates Stem Cell Niche to Potentially Reverse Follicle Miniaturization (GlobeNewswire)
Dec-10-25 08:00AM	Absci and U.S. Soccer Legend Landon Donovan Partner to Champion the Patient Voice in Hair Loss Research (GlobeNewswire) +12.78%
Dec-05-25 10:37AM	ABSI Stock Up on Initiating Dosing in Androgenetic Alopecia Study (Zacks)
Dec-04-25 08:00AM	Absci Announces First Participants Dosed in Phase 1/2a HEADLINE Trial of AI-Designed Antibody ABS-201 for Androgenetic Alopecia (GlobeNewswire) +13.37%
06:05AM	10 AI Stocks Worth Buying Right Now (Motley Fool)
Nov-13-25 12:02AM	Absci Corp (ABSI) Q3 2025 Earnings Call Highlights: Strategic Shifts and Strong Cash Position ... (GuruFocus.com) -22.35%
Nov-12-25 05:25PM	Absci Corporation (ABSI) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
04:05PM	Absci Reports Business Updates and Third Quarter 2025 Financial and Operating Results (GlobeNewswire)
Nov-11-25 07:28AM	Absci Corp (ABSI) Q3 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Nov-10-25 08:15AM	uniQure (QURE) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
Nov-06-25 09:15AM	Invivyd, Inc. (IVVD) Reports Q3 Loss, Lags Revenue Estimates (Zacks) -5.77%
Oct-29-25 04:05PM	Absci to Report Business Updates and Third Quarter 2025 Financial and Operating Results on November 12, 2025 (GlobeNewswire) -6.41%
Oct-27-25 08:00AM	Absci to Participate in Upcoming Investor Conferences (GlobeNewswire) +5.39%
Oct-15-25 08:00AM	Absci to Host KOL Seminar on ABS-201 Androgenetic Alopecia Program on December 11, 2025; Announces Accelerated Initiation of Phase 1/2a Trial (GlobeNewswire) +28.21%
Oct-13-25 12:12PM	2 Reasons Absci Could Be the Future of AI Biotech, and 1 Risk (MarketBeat)
Sep-21-25 09:26AM	Absci Corporation (ABSI) Secures $64M Financing to Drive AI Drug Discovery Through 2028 (Insider Monkey)
Sep-11-25 08:00AM	Absci Accelerates AI-Driven Drug Discovery with Oracle and AMD (GlobeNewswire) +15.13%
Aug-25-25 04:05PM	Absci Expands ABS-201 Scientific Advisory Board with Addition of Leading Dermatology Experts Dr. Rodney Sinclair and Dr. David Goldberg (GlobeNewswire)
Aug-20-25 08:00AM	Absci to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-13-25 03:12AM	Absci Corp (ABSI) Q2 2025 Earnings Call Highlights: Strategic Advances Amid Revenue Challenges (GuruFocus.com) +5.05%
Aug-12-25 05:20PM	Absci Corporation (ABSI) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
04:05PM	Absci Reports Business Updates and Second Quarter 2025 Financial and Operating Results (GlobeNewswire)
Aug-11-25 09:31AM	Absci Corp (ABSI) Q2 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
Aug-07-25 10:00AM	SAB Biotherapeutics, Inc. (SABS) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release (Zacks)
02:00AM	Almirall and Absci Expand AI Drug Creation Collaboration Adding a Second Dermatology Target (GlobeNewswire)
Aug-06-25 10:00AM	Absci Corporation (ABSI) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Aug-05-25 05:15PM	Amgen (AMGN) Beats Q2 Earnings and Revenue Estimates (Zacks)
Aug-04-25 05:15PM	Syndax Pharmaceuticals (SNDX) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
Jul-30-25 04:05PM	Absci to Report Business Updates and Second Quarter 2025 Financial and Operating Results on August 12, 2025 (GlobeNewswire)
Jul-25-25 09:56AM	Coya Therapeutics, Inc. (COYA) Surges 10.7%: Is This an Indication of Further Gains? (Zacks) -17.66%
Jul-24-25 08:45PM	Absci Announces Pricing of Public Offering of Common Stock (GlobeNewswire)
04:54PM	Absci Announces Proposed Public Offering of Common Stock (GlobeNewswire)
Jul-11-25 07:15PM	Morgan Stanley Assumes Coverage on Absci Corporation (ABSI) with $7 Target (Insider Monkey)
Jul-07-25 08:30AM	iRhythm Technologies Announces Board Member Retirements and New Director Appointments (GlobeNewswire) -6.86%
08:00AM	Absci Appoints Biopharma Leader Mary Szela to Board of Directors (GlobeNewswire)
May-20-25 08:00AM	Absci to Participate in Upcoming Investor Conferences (GlobeNewswire)
May-14-25 08:32AM	Q1 2025 Absci Corp Earnings Call (Thomson Reuters StreetEvents)
03:17AM	Absci Corp (ABSI) Q1 2025 Earnings Call Highlights: Transition to Clinical Stage and Strong ... (GuruFocus.com)
May-13-25 05:30PM	Absci Corporation (ABSI) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:05PM	Absci Reports Business Updates and First Quarter 2025 Financial and Operating Results (GlobeNewswire)
04:01PM	Absci Announces First Participants Dosed in Phase 1 Clinical Trial of ABS-101, a Potential Best-In-Class anti-TL1A Antibody for the Treatment of Inflammatory Bowel Disease (GlobeNewswire)
May-12-25 09:35AM	What To Expect From Absci Corp (ABSI) Q1 2025 Earnings (GuruFocus.com) +6.55%
Apr-14-25 04:05PM	Absci to Report Business Updates and First Quarter 2025 Financial and Operating Results on May 13, 2025 (GlobeNewswire)
11:40AM	Absci: FDA Announcement Provides Only A Modest Tailwind (Seeking Alpha)
Apr-03-25 03:15PM	Absci Corporation: A Potential Turnaround Play In Biotech Amid A Tumultuous Market (Seeking Alpha) -9.88%
Mar-31-25 07:15AM	Which Healthcare Stock Is the Best Buy Right Now? (MarketBeat) -7.04%
Mar-26-25 08:00AM	Absci to Participate in Upcoming Investor Conferences (GlobeNewswire) -5.54%
Mar-21-25 10:57PM	Absci Corp (ABSI) Q4 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Mar-19-25 09:08AM	Q4 2024 Absci Corp Earnings Call (Thomson Reuters StreetEvents)
03:03AM	Absci Corp (ABSI) Q4 2024 Earnings Call Highlights: Strategic Collaborations and Financial ... (GuruFocus.com)
Mar-18-25 04:05PM	Absci Reports Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results (GlobeNewswire)
Mar-04-25 04:05PM	Absci to Report Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results on March 18, 2025 (GlobeNewswire)
04:00PM	Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
08:00AM	Absci to Participate in the KeyBanc Capital Markets Healthcare Forum (GlobeNewswire)
Mar-01-25 05:19PM	Why Absci Corporation (ABSI) is Skyrocketing So Far in 2025 (Insider Monkey)
Feb-18-25 08:00AM	Absci to Participate in the TD Cowen 45th Annual Health Care Conference (GlobeNewswire)
Feb-12-25 09:24AM	Is Absci Corp. (ABSI) the Best Nasdaq Stock Under $5 to Buy? (Insider Monkey)

Absci Corp. engages in drug discovery with generative design to create biologics for patients. Its platform combines AI models with a synthetic biology data engine, enabling the design of therapeutics that address challenging therapeutic targets. The firm has its own pipeline of AI designed therapeutics including ABS-201 and ABS-202. Absci Corp was founded by Sean McClain in 2011 and is headquartered in Vancouver, WA.

FounderMr. Sean McClain

Chief Business Officer & CFODr. Zachariah Jonasson Ph.D.

Senior VP & Chief Accounting OfficerMr. Todd Bedrick CPA

CVP of Finance & Head of Investor RelationsMr. Alexander Khan CPA

Chief Legal OfficerMs. Shelby Walker J.D.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Szela Mary T	Director	Jun 30 '26	Buy	11.54	12,900	148,866	21,300	Jul 06 04:06 PM
Pangalos Menelas N	Director	May 13 '26	Buy	5.36	37,453	200,748	232,308	May 13 04:05 PM
Busch Andreas	Chief Innovation Officer	Mar 12 '26	Buy	2.29	100,000	229,000	421,446	Mar 16 04:17 PM
Pangalos Menelas N	Director	Feb 27 '26	Buy	2.74	75,095	205,760	189,055	Mar 03 04:13 PM
McClain Sean	Chief Executive Officer	Feb 23 '26	Option Exercise	1.21	396,399	479,643	8,730,966	Feb 25 06:05 PM
McClain Sean	Chief Executive Officer	Feb 02 '26	Sale	2.99	26,761	80,015	8,334,567	Feb 04 04:52 PM
Jonasson Zachariah	CFO / CBO	Feb 02 '26	Sale	2.99	17,496	52,313	383,538	Feb 04 04:51 PM
VAN HOUTEN FRANS	Director	Dec 05 '25	Buy	3.72	40,000	148,800	63,320	Dec 09 04:04 PM
Pangalos Menelas N	Director	Sep 22 '25	Buy	2.66	95,785	254,788	113,960	Sep 24 04:03 PM
Bedrick Todd	SVP, CAO	Sep 22 '25	Buy	2.70	10,000	27,000	180,428	Sep 24 04:03 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ABSI

Absci Corp

Upgrade your Finviz experience